Biological E collaborate with Bavarian Nordic to expand Chikungunya Vaccine access in low, middle income countries Ruchika Sharma1 March 2025 4:30 AMHyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian Nordic's Chikungunya...
Biological E gets WHO pre-qualification status for oral polio vaccine Ruchika Sharma31 July 2024 6:08 AM Hyderabad: In a stride towards eradicating polio worldwide, Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company has...
Pneubevax 14 safe, immunogenic in 6-8 week old infants: Biological E Ruchika Sharma1 May 2024 8:50 AMPNEUBEVAX 14 was found to be safe and induced robust and functional serotype specific immune responses to all 14 serotypes.
International Vaccine Institute begins technology transfer of Oral Cholera Vaccine to Biological E Ruchika Sharma21 March 2024 7:18 AMIVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured for India and international markets by Biological...
Biological E, Takeda join hands to accelerate access to Dengue Vaccine in endemic areas Ruchika Sharma29 Feb 2024 9:30 AMHyderabad: Takeda and Biological E. Limited (BE), an India-based Vaccines and Pharmaceutical Company, has announced a strategic partnership...
Biological E Corbevax vaccine gets WHO Emergency Use Listing authorisation Roshni Dhar18 Jan 2024 11:58 AMBiological E. Limited, a Hyderabad-based Vaccines and Pharmaceutical company, has announced that the World Health Organisation (WHO) has granted an...
WHO grants Emergency Use Listing to Biological E Corbevax vaccine Ruchika Sharma17 Jan 2024 7:04 AMHyderabad: Biological E. Limited, a Hyderabad-based Vaccines and Pharmaceutical company, has announced that the World Health Organisation (WHO)...
Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 9:13 AMBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate Vaccine Ruchika Sharma17 Dec 2022 6:03 AMBE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s...
Biological E Corbevax safe, immunogenic in 5-18 age group Ruchika Sharma3 Nov 2022 11:00 AMHyderabad: Biological E. Limited, a Hyderabad-based vaccine, and pharmaceutical company, today announced the publication of CORBEVAX COVID-19 vaccine...
Biological E Corbevax offers better immunity as heterologous booster shot Ruchika Sharma14 Oct 2022 7:00 AMCORBEVAX can be administered as a booster six months after two doses of COVAXIN or COVISHIELD for all adults.
CDSCO panel recommends Biological E 14-valent paediatric vaccine against S pneumonia Ruchika Sharma2 Sept 2022 7:25 AMNew Delhi: Biological E Limited on Thursday announced that the Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO)...
